From long COVID-19 to vaccine efficacy to maternal outcomes, Becker's covered dozens of COVID-19-focused studies since the start of the year.
Patient Safety & Outcomes
Nearly 20 percent of COVID-19 survivors may experience lingering, worsening or new-onset symptoms two years after infection, according to a study of nearly 2,000 patients who were hospitalized at the start of the pandemic in Wuhan, China.
As abortion bans are enacted across the U.S., physicians are struggling to determine how legislation will affect what cancer treatments can be offered to pregnant patients, Kaiser Health Network reported Sept. 16.
Adults 65 and older who contract COVID-19 may be at greater risk for new-onset Alzheimer's disease, according to a study published Sept. 13 in the Journal of Alzheimer's Disease.
Physician burnout is associated with a reduction in care quality, a Sept. 14 study published in The BMJ found.
Medication safety is the core focus of the World Health Organization's 2022 World Patient Safety Day, held annually on Sept. 17.
Arlington-based Texas Health Resources is the 2022 recipient of the American Society for Health Care Risk Management's Patient Safety Award, the health system said Sept. 14.
Flushing the nasal cavity with a mild saline solution may significantly reduce the risk of hospitalization and death after testing positive for COVID-19, according to a recent study published in Ear, Nose & Throat Journal.
There isn't enough evidence to support widespread screening of Type 2 diabetes in children and adolescents in the U.S., a panel of national experts on disease prevention said Sept. 13.
Some long COVID-19 patients still have impaired or loss of smell one year after symptom onset, suggesting the condition could be permanent, according to a small study published Sept. 8 in JAMA Network Open.